🇨🇦 dexmedetomidine-esketamine-ropivacaine combination 2 in Canada

dexmedetomidine-esketamine-ropivacaine combination 2 (dexmedetomidine-esketamine-ropivacaine combination 2) regulatory status in Canada.

Marketing authorisation

dexmedetomidine-esketamine-ropivacaine combination 2 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is dexmedetomidine-esketamine-ropivacaine combination 2 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for dexmedetomidine-esketamine-ropivacaine combination 2 in Canada?

Peking University First Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.